KEGG   PATHWAY: aamp05216
Entry
aamp05216                   Pathway                                
Name
Thyroid cancer - Arvicola amphibius (Eurasian water vole)
Description
Thyroid cancer is the most common endocrine malignancy and accounts for the majority of endocrine cancer- related deaths each year. More than 95% of thyroid carcinomas are derived from follicular cells. Their behavior varies from the indolent growing, well-differentiated papillary and follicular carcinomas (PTC and FTC, respectively) to the extremely aggressive undifferentiated carcinoma (UC). Somatic rearrangements of RET and TRK are almost exclusively found in PTC and may be found in early stages. The most distinctive molecular features of FTC are the prominence of aneuploidy and the high prevalence of RAS mutations and PAX8-PPAR{gamma} rearrangements. p53 seems to play a crucial role in the dedifferentiation process of thyroid carcinoma.
Class
Human Diseases; Cancer: specific types
Pathway map
aamp05216  Thyroid cancer
aamp05216

Organism
Arvicola amphibius (Eurasian water vole) [GN:aamp]
Gene
119807136  Ret; proto-oncogene tyrosine-protein kinase receptor Ret [KO:K05126] [EC:2.7.10.1]
119823194  Ccdc6; coiled-coil domain-containing protein 6 [KO:K09288]
119827782  Ncoa4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
119800869  Ntrk1; high affinity nerve growth factor receptor isoform X1 [KO:K03176] [EC:2.7.10.1]
119800649  Tpm3; tropomyosin alpha-3 chain isoform X1 [KO:K09290]
119827428  Tpr; nucleoprotein TPR [KO:K09291]
119825146  Tfg; protein TFG isoform X1 [KO:K09292]
119800249  Hras; GTPase HRas isoform X1 [KO:K02833]
119801497  Nras; GTPase NRas [KO:K07828]
119804230  GTPase KRas-like [KO:K07827]
119806318  Kras; GTPase KRas isoform X1 [KO:K07827]
119806667  Braf; LOW QUALITY PROTEIN: serine/threonine-protein kinase B-raf [KO:K04365] [EC:2.7.11.1]
119809903  Map2k1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
119827491  Map2k2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
119824680  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
119813356  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
119819719  Pax8; paired box protein Pax-8 [KO:K09293]
119807937  Pparg; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
119818907  Rxra; retinoic acid receptor RXR-alpha isoform X1 [KO:K08524]
119822749  Rxrb; retinoic acid receptor RXR-beta isoform X3 [KO:K08525]
119827442  Rxrg; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
119818608  cellular tumor antigen p53-like [KO:K04451]
119813419  Tp53; cellular tumor antigen p53 [KO:K04451]
119823049  Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625]
119822349  Gadd45b; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
119816942  Gadd45g; growth arrest and DNA damage-inducible protein GADD45 gamma isoform X1 [KO:K04402]
119807493  Gadd45a; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
119802627  Bax; apoptosis regulator BAX isoform X1 [KO:K02159]
119823918  Bak1; bcl-2 homologous antagonist/killer [KO:K14021]
119815700  Ddb2; DNA damage-binding protein 2 [KO:K10140]
119809608  Polk; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
119802116  Cdh1; cadherin-1 [KO:K05689]
119808978  Ctnnb1; catenin beta-1 [KO:K02105]
119812304  Tcf7; transcription factor 7 isoform X1 [KO:K02620]
119807723  Tcf7l1; transcription factor 7-like 1 isoform X1 [KO:K04490]
119806595  Tcf7l2; transcription factor 7-like 2 isoform X1 [KO:K04491]
119800683  Lef1; lymphoid enhancer-binding factor 1 [KO:K04492]
119822940  Myc; myc proto-oncogene protein [KO:K04377]
119827335  Ccnd1; G1/S-specific cyclin-D1 [KO:K04503]
Reference
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Related
pathway
aamp03320  PPAR signaling pathway
aamp04010  MAPK signaling pathway
aamp04115  p53 signaling pathway
aamp04310  Wnt signaling pathway
aamp04520  Adherens junction
KO pathway
ko05216   
LinkDB

DBGET integrated database retrieval system